HTFL vs LFST
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HTFL exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health and operational inefficiency. While the company maintains a strong liquidity position (Current Ratio 5.20) and impressive revenue growth of 40.5%, these are offset by deep negative profit margins (-66.35%) and a high Price/Sales multiple of 13.13. The combination of heavy insider selling ($62.54M) and consistent earnings misses suggests a significant disconnect between analyst optimism and internal sentiment.
LFST presents a stable but precarious financial profile with a Piotroski F-Score of 4/9 and no Altman Z-Score provided for bankruptcy risk assessment. While the company has successfully transitioned toward profitability with a promising forward P/E of 16.74, it trades at a massive premium compared to its Graham Number ($1.33) and Intrinsic Value ($0.14). Strong revenue growth of 17.4% is offset by razor-thin profit margins (0.68%) and aggressive insider selling totaling $32.51M. The stock is currently a speculative play on earnings expansion rather than a value-driven investment.
Compare Another Pair
Related Comparisons
HTFL vs LFST: Head-to-Head Comparison
This page compares Heartflow, Inc. (HTFL) and LifeStance Health Group, Inc. (LFST) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.